ES2009227A6 - Un procedimiento para la preparacion de un compuesto de oxindol farmaceuticamente activo. - Google Patents

Un procedimiento para la preparacion de un compuesto de oxindol farmaceuticamente activo.

Info

Publication number
ES2009227A6
ES2009227A6 ES8703589A ES8703589A ES2009227A6 ES 2009227 A6 ES2009227 A6 ES 2009227A6 ES 8703589 A ES8703589 A ES 8703589A ES 8703589 A ES8703589 A ES 8703589A ES 2009227 A6 ES2009227 A6 ES 2009227A6
Authority
ES
Spain
Prior art keywords
compound
oxindol
preparation
pharmaceutically active
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8703589A
Other languages
English (en)
Inventor
Saul Bernard Kadin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/825,017 external-priority patent/US4678802A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES2009227A6 publication Critical patent/ES2009227A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

UN PROCEDIMIENTO PARA LA PREPARACION DE UN COMPUESTO DE OXINDO1 FARMACEUTICAMENTE ACTIVO DE FORMULA (I) DONDE R1 ES H, ALQUILO, CICLOALQUILO C3-7, HETEROCICLO, OPCIONALMENTE METILADO; X ES H, HALOGENO, ALQUILO, ALQUILTIO, CICLOALQUILO C3-6, ACILO; Y ES H, HALOGENO, ALQUILO, ALCOXI O ALQUILTIO; X E Y SI SE CONSIDERAN CONJUNTAMENTE SON 4,5-, 5,6-, O 6,7-METILENDIOXI; A ES ALQUILO, UN GRUPO AMINO O UN GRUPO AMIDO. EL PROCEDIMIENTO CONSISTE EN HACER REACCIONAR UN COMPUESTO DE OXINDOL DE FORMULA (II) CON UNA AMINA R1N
ES8703589A 1985-07-09 1987-12-15 Un procedimiento para la preparacion de un compuesto de oxindol farmaceuticamente activo. Expired ES2009227A6 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75320085A 1985-07-09 1985-07-09
US82129686A 1986-01-22 1986-01-22
US06/825,017 US4678802A (en) 1985-07-09 1986-01-31 1-acylcarbamoyloxindole-3-carboxamides as antiinflammatory agents

Publications (1)

Publication Number Publication Date
ES2009227A6 true ES2009227A6 (es) 1989-09-16

Family

ID=27419443

Family Applications (2)

Application Number Title Priority Date Filing Date
ES8600191A Expired ES2001855A6 (es) 1985-07-09 1986-07-08 Un procedimiento para la preparacion de un compuesto de oxindol farmaceuticamente activo
ES8703589A Expired ES2009227A6 (es) 1985-07-09 1987-12-15 Un procedimiento para la preparacion de un compuesto de oxindol farmaceuticamente activo.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES8600191A Expired ES2001855A6 (es) 1985-07-09 1986-07-08 Un procedimiento para la preparacion de un compuesto de oxindol farmaceuticamente activo

Country Status (19)

Country Link
EP (1) EP0208510B1 (es)
JP (1) JPH0610193B2 (es)
CN (1) CN86105309A (es)
AT (1) ATE67185T1 (es)
AU (1) AU566065B2 (es)
CA (1) CA1286663C (es)
DE (1) DE3681358D1 (es)
DK (1) DK324286A (es)
ES (2) ES2001855A6 (es)
FI (1) FI862882L (es)
GR (1) GR861760B (es)
HU (2) HUT41386A (es)
IE (1) IE58566B1 (es)
IL (1) IL79356A (es)
NO (1) NO862750L (es)
NZ (1) NZ216788A (es)
PH (1) PH22641A (es)
PT (1) PT82931B (es)
YU (2) YU45346B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE68593B1 (en) * 1989-12-06 1996-06-26 Sanofi Sa Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
FR2655344B1 (fr) * 1989-12-06 1992-04-03 Sanofi Sa Derives heterocycliques d'acylaminothiazoles, leur preparation et compositions pharmaceutiques en contenant.
WO1991009598A1 (en) * 1990-01-05 1991-07-11 Pfizer Inc. Azaoxindole derivatives
FR2677356B1 (fr) * 1991-06-05 1995-03-17 Sanofi Sa Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant.
JPH08288983A (ja) * 1995-04-17 1996-11-01 Tokyo Tsuuki:Kk リンガ回路
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
CA2416397A1 (en) 2000-07-19 2003-01-16 Ube Industries, Ltd. Process for producing 5-fluorooxyindole and for producing intermediate therefor
WO2002070478A1 (en) 2001-03-06 2002-09-12 Astrazeneca Ab Indolone derivatives having vascular-damaging activity
JP4770826B2 (ja) * 2007-11-22 2011-09-14 大日本印刷株式会社 ２−オキシインドール誘導体の製造法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
US3882236A (en) 1973-12-26 1975-05-06 Lilly Co Eli Pharmaceutical compositions containing substituted 2-oxo-indolines and the use thereof to treat anxiety and tension
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4690943A (en) * 1984-09-19 1987-09-01 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds

Also Published As

Publication number Publication date
HU198015A (en) 1989-07-28
FI862882A0 (fi) 1986-07-08
EP0208510B1 (en) 1991-09-11
PT82931B (pt) 1989-01-30
JPS6226269A (ja) 1987-02-04
FI862882A7 (fi) 1987-01-10
FI862882L (fi) 1987-01-10
DK324286A (da) 1987-01-10
IE861833L (en) 1987-01-09
IL79356A0 (en) 1986-10-31
DE3681358D1 (de) 1991-10-17
AU5984786A (en) 1987-04-09
CN86105309A (zh) 1987-01-14
JPH0610193B2 (ja) 1994-02-09
ES2001855A6 (es) 1988-07-01
YU114487A (en) 1988-02-29
AU566065B2 (en) 1987-10-08
EP0208510A2 (en) 1987-01-14
HUT41386A (en) 1987-04-28
PT82931A (en) 1986-08-01
NO862750D0 (no) 1986-07-08
GR861760B (en) 1986-11-10
IE58566B1 (en) 1993-10-06
ATE67185T1 (de) 1991-09-15
IL79356A (en) 1990-03-19
DK324286D0 (da) 1986-07-08
EP0208510A3 (en) 1988-03-02
NO862750L (no) 1987-01-12
CA1286663C (en) 1991-07-23
PH22641A (en) 1988-10-28
YU45346B (en) 1992-05-28
NZ216788A (en) 1988-10-28
YU120386A (en) 1988-02-29

Similar Documents

Publication Publication Date Title
ES2009227A6 (es) Un procedimiento para la preparacion de un compuesto de oxindol farmaceuticamente activo.
AR241528A1 (es) Un procedimiento para la preparacion de n-(3- o 4-((alquilamino)alquil)-fenil)alcansulfonamidas y sus sales.
FI872864L (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
PT82854B (pt) Processo para a preparacao de derivados do acido piridono-carboxilico
ES8703142A1 (es) Proceso para preparar un derivado del bencimidazol.
ES8802521A1 (es) Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas
ATE219077T1 (de) Endothelin antagoniste
FI850140L (fi) Kemiska foereningar.
TR199900897T2 (xx) Ornat�lm�� aminoalkanfosfonik asitler.
ES523191A0 (es) Procedimiento para la preparacion de 1-ariloxi-2,3,4,5-tetrahidro-3-benzazepinas
ES2053439T3 (es) Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
DE3772015D1 (de) Chinolinverbindung.
ATE45354T1 (de) Chinoloncarbonsaeurederivate.
JO1484B1 (en) Chemical compounds
ATE62483T1 (de) N-alkylierung von dihydrolysergsaeure.
DK184085D0 (da) Heterocycliske aminoforbindelser
NO871575D0 (no) Fremgangsmaate for fremstilling av 1,5-benztiazepinderivater.
ES8706628A1 (es) Procedimiento para la preparacion de 2-(piridil e imidazolil)-indoles.
EP0216323A3 (en) Quinolonecarboxylic acid derivatives and their preparation
DK439286A (da) Propanolderivater
GR81771B (es)
DE3482110D1 (de) Verfahren zur bereitung von 7-(2-hexyl-5-hydroxy-zyklopentyl)heptansaeure.
ES2040223T3 (es) Derivados de la tiadiazolilacetamida, procedimiento para su fabricacion y su utilizacion.
AR240920A2 (es) "un procedimiento para la preparacion de nuevos derivados de quinolina".
PT84760B (pt) Processo de preparacao de derivados de tiadiazinona, de seus intermediarios e de composicoes farmaceuticas